In silico Platform for designing genome-based
Personalized immunotherapy or Vaccine against Cancer

Predicted Immune Epitope Results

The result page of search shows exclusive peptide/epitopes generated due to mutation [Neoepitope], the tissue of origin [Tissue], position of peptide in protein [Position], number of mismatches counted by aligning mutated and normal protein sequence [Num Mismatch, percentage of cell lines with this peptide over total number of cell lines [Promiscuity %]. The immune information include CTL epitopes (Yes/No), MHC I binders, MHC II binders (both given as number of alleles) and B cell epitopes (Yes/No). For more information, please click HERE

NeoepitopesMLQIINIVL        Click here to BLAST against human proteome
CTL Epitope
HLA I Alleles
(ProPred I)
HLA-A*0201, HLA-A*0205, HLA-A2.1, HLA-A24, HLA-A3, HLA-B*2705, HLA-B*3701, HLA-B*3902, HLA-B*51, HLA-B*5201, HLA-B*5301, HLA-B62, HLA-B7, HLA-Cw*0602, MHC-Dd, MHC-Kb16
HLA I Alleles
HLA-Cw*0401, H2-Db, H2-Dd, H2-Kb, H2-Kd, H2-Ld, HLA-G, H-2Qa, Mamu-A*019
HLA II Alleles
DRB1_0101, DRB1_0102, DRB1_0402, DRB1_0404, DRB1_0405, DRB1_0408, DRB1_0410, DRB1_0423, DRB1_0701, DRB1_0703, DRB1_1501, DRB1_1502, DRB1_1506, DRB5_0101, DRB5_010515

CANCERTOPE    |     Raghava's Group    |     IMTECH    |     CSIR    |     CRDD    |     GPSR Package